# DYNAVAX TECHNOLOGIES CORP: Form D filings

DYNAVAX TECHNOLOGIES CORP, a biotechnology company in Berkeley, CA, filed 2 Form D notices with the SEC in 2010. The latest, on May 25, 2010, reports $181,000 sold of a $181,000 offering to 1 investor.

Find out what DYNAVAX TECHNOLOGIES CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20DYNAVAX%20TECHNOLOGIES%20CORP%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=DYNAVAX%20TECHNOLOGIES%20CORP&page=%2Fdata%2Fform-d%2Fcompany%2Fdynavax-technologies-corp-1029142)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20DYNAVAX%20TECHNOLOGIES%20CORP%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=DYNAVAX%20TECHNOLOGIES%20CORP&page=%2Fdata%2Fform-d%2Fcompany%2Fdynavax-technologies-corp-1029142)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2929 SEVENTH STREET, SUITE 100, Berkeley, CA, 94710
- Phone: (510) 848-5100
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: $25,000,001 - $100,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1029142

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 25, 2010 | New notice | $181,000 | $181,000 | $0 | 1 | May 11, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1029142/000128832010000006/0001288320-10-000006-index.htm) |
| Jan 7, 2010 | New notice | $38,947,480 | $20,067,480 | $18,880,000 | 15 | Dec 30, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1029142/000128832010000001/0001288320-10-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Denise M. Gilbert, Ph.D. | Director |  |
| Peggy V. Philips | Director |  |
| Mark M. Kessel | Director |  |
| Dino Dina, M.D. | Executive Officer, Director |  |
| David M. Lawrence, M.D. | Director |  |
| Dennis R. Carson, M.D. | Director |  |
| Francis R. Cano, Ph.D. | Director |  |
| Zbigniew L. Janowicz, Ph.D. | Executive Officer |  |
| Jennifer S. Lew | Executive Officer |  |
| Stanley A. Plotkin, M.D. | Director |  |
| Arnold S. Oronsky, Ph.D. | Director |  |
| Michael S. Ostrach | Executive Officer |  |
| Robert L. Coffman, Ph.D. | Executive Officer |  |
| Nancy L. Buc | Director |  |

## Other biotechnology companies in California that filed recently

- [CARI Health, Inc.](https://specstream.ai/data/form-d/company/cari-health-inc-1930994) $280,000 · Nov 6, 2026
- [Ausel, Inc.](https://specstream.ai/data/form-d/company/ausel-inc-2124022) $120,000 · Nov 4, 2026
- [Trellis Bioscience, Inc.](https://specstream.ai/data/form-d/company/trellis-bioscience-inc-1162015) $9.1 million · Oct 29, 2026
- [BigHat Biosciences, Inc.](https://specstream.ai/data/form-d/company/bighat-biosciences-inc-1797256) $75.1 million · Oct 26, 2026
- [Theravie Pharma, Inc.](https://specstream.ai/data/form-d/company/theravie-pharma-inc-2160768) $750,000 · Oct 19, 2026
- [Adela, Inc.](https://specstream.ai/data/form-d/company/adela-inc-1852167) $12 million · Oct 19, 2026
- [Estuary Biotherapeutics, Inc.](https://specstream.ai/data/form-d/company/estuary-biotherapeutics-inc-2138862) $40.7 million · Oct 16, 2026
- [Renue Life Sciences, Inc.](https://specstream.ai/data/form-d/company/renue-life-sciences-inc-2158207) $250,000 · Oct 14, 2026
- [Tempest Therapeutics, Inc.](https://specstream.ai/data/form-d/company/tempest-therapeutics-inc-1544227) $7.5 million · Oct 14, 2026
- [Lionheart Health, Inc.](https://specstream.ai/data/form-d/company/lionheart-health-inc-2156758) $387,500 · Oct 7, 2026
- [Rakuten Medical, Inc.](https://specstream.ai/data/form-d/company/rakuten-medical-inc-1595215) $9 million · Oct 6, 2026
- [Zonaliz, Inc.](https://specstream.ai/data/form-d/company/zonaliz-inc-2157556) $2.5 million · Oct 5, 2026
- [Altay Therapeutics, Inc.](https://specstream.ai/data/form-d/company/altay-therapeutics-inc-2157551) $15.7 million · Oct 2, 2026
- [Sialia Therapeutics, Inc.](https://specstream.ai/data/form-d/company/sialia-therapeutics-inc-2156754) $1.5 million · Sep 29, 2026
- [Vetmab Biosciences, Inc.](https://specstream.ai/data/form-d/company/vetmab-biosciences-inc-1932050) $11.4 million · Sep 29, 2026

[Every Form D from the week of May 24, 2010](https://specstream.ai/data/form-d/week/2010-05-24) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what DYNAVAX TECHNOLOGIES CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).